3Mazzuchi N,Carbonell E,Fernandez-Cean J.Importance of blood pressure control in hemodialysis patient survival.Kidney Int,2000,58(5):2147-2154.
4Charra B.From adequate to optimal dialysis Long 3×8 hr dialysis:a reasonable compromise.Nefrologia,2005,25 (Suppl 2):19-24.
5Dionisio P,Valenti M,Bergia R,et al.Influence of the hydration state on blood Pressure values in a group of Patients on regular maintenance hemodialysis.Blood Puri,1997,15(1):25.
6Kitiyakara C,Chabrashvili T,Chen Y,et al.Salt intake,oxidative stress,and renal expression of NADPH oxidase and superoxide dimutase.J Am Soc Nephrol,2003,14 (11):2775-2782.
7Verhave JC,Hillege HL,Burgerhof JG,et al.Sodium intake affects urinary albumin excretion especially in overweight subjects.J Inter Med,2004,256(4):324-330.
8Grekas D,Kalevrosoglou I,Karamouzis M,et al.Effect of sympathetic and plasma renin activity on hemodialysis hypertension.Clin Nephrol,2001,55(2):115-120.
9John TD,Todd SI.Hypertension handbook of dialysis.Seeondedition,Boston:1994.433-444.
10Landry DW,Oliver JA.Blood pressure instability during hemodialysis.Kidney Int,2006,69(10):1710-1711.
4Barsoum RS. Overview : End stage renal disease in the developing world. Artif Organs, 2002,26 (9):737-46
5Agarwal SK, Dash SC. Spectrum of renal diseases in Indian adults. J Assoc Physicians India, 2000,48(6):594-600
6Bommer J Prevalence and socio-economic aspects of chronic kidney disease Nephrol Dial Transplant, 2002,17 Suppl 11:8-12
7Haubitz M, Brunkhorst R. C-reactive protein and chronic Chlamydia pneumonia infection-long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant, 2001,16:809-815
8Stenvinkel P, Heimburger O, Pautre F, et al: Strong association between malnutrition, inflamation, and atherosclerosis in chronic renal failure. Kidney int, 1999, 55:648-658
9Cooper BA, Penne EL, Bartlett LH. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis, 2004, 43:61-66
10Bommer J, Alexiou C, Muller - Buhl U, et al. Recombinant Human erythropoietin therapy in haemodialysis patients-dose determination and clinical experience. Nephrol Dial Transplant, 1998,2 (4): 238 - 242.
6Kurajoh [J].Inaba M,Yamada S,et al .Association of increased active PTH (1-84)fraction with decreased GFR and serum Ca in predialysis CRF patients: modulationby serum 25-OH-D[J].Osteoporos Int,2008; 19(5):709 — 716.
7Nakao K, Mochizuki, H. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients. Drugs of Today ,2009,45 ( 5 ) :323 - 329.
8Che- Yi C, Wen CY, MinTsung K, et al. Acupuncture in hae- modialysis patients at the Quchi (LI11 ) acupoint for refractory uraemic pruritus. Nephrol Dial Transplant, 2005,20 ( 9 ) : 1912 -1915.
9Agarwal R. Epidemiology of interdialytic ambulatory hypertension and the role of volume excess[J].American Journal of Nephrology,2011.381-390.
10Charra B. From adequate to optimal dialysis long 3 x 8 hr dialysis:a reasonable compromise[J].Nephrologie,2005,(Suppl 2):s19-s24.
